SCHEMBL4746339

SCHEMBL4746339

Cc1ccc2c(c1)c(-c1ccc(-c3cc4c5ccc(C)c6c5c(cc4c4ccc(C)cc34)-c3ncccc3-6)cc1)cc1c3ccc(C)c4c3c(cc21)-c1ncccc1-4

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.36
COMT P21964 1/20 0.33
BCHE P06276 1/20 0.33
ALDH1A1 P00352 3/20 0.32
KDM4E B2RXH2 3/20 0.32
MEN1 O00255 2/20 0.32
MAPT P10636 2/20 0.32
KMT2A Q03164 2/20 0.32
LMNA P02545 1/20 0.32
RECQL P46063 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
GRM2 Q14416 1/20 0.32
MKNK1 Q9BUB5 1/20 0.32
MKNK2 Q9HBH9 1/20 0.32
PDK2 Q15119 1/20 0.31
ADK P55263 1/20 0.31
SQOR Q9Y6N5 1/20 0.31
PTGS1 P23219 2/20 0.31
PTGS2 P35354 2/20 0.31
IL1B P01584 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4746317 0.99 DHODH (0.35) DHODHCOMTBCHEALDH1A1KDM4E
SCHEMBL4745792 0.95 BCHE (0.40) DHODHCOMTBCHEALDH1A1KDM4E
SCHEMBL4746312 0.93 BCHE (0.34) DHODHCOMTBCHEALDH1A1KDM4E
SCHEMBL4746389 0.93 DHODH (0.34) DHODHBCHEALDH1A1KDM4ELMNA
SCHEMBL4746310 0.93 BCHE (0.34) DHODHBCHEALDH1A1KDM4EMEN1
SCHEMBL4746387 0.92 DHODH (0.33) DHODHBCHEALDH1A1KDM4ELMNA
SCHEMBL4746394 0.90 MEN1 (0.32) BCHEALDH1A1KDM4EMEN1MAPT
SCHEMBL4745812 0.90 ALDH1A1 (0.34) DHODHBCHEALDH1A1KDM4ESMN1; SMN2
SCHEMBL4745843 0.90 BCHE (0.40) DHODHBCHEALDH1A1KDM4EMEN1
SCHEMBL4745791 0.90 BCHE (0.37) DHODHBCHEALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE NR2E3, OR51E2, AZI2 DHODH 18/4885COMT 405/4885BCHE 376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.